February 11, 2025
First drug developed by generative AI administered to patients

Insilico Medicine, a biotechnology company based in Hong Kong, announced that human patients have begun receiving the drug INS018_055, an anti-fibrotic small molecule inhibitor…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *